Thanks, I will do more study based on your input.
PS: Could it ever make sense for Atryn in some form to be prescribed as a medication for severe RA, or other inflammatory condition? I guess I am wondering to what degree are the anti-inflammatory properties present; just enough to make a difference in another primary treatment (DIC) or is the effect significant enough to make a real difference with inflammation as a primary target? It would seem that, intuitively, the treatment would be too risky for that kind of primary usage but I thought I'd ask.
Market Data 
Markets 
AI
